2026 AAHFN CME Symposium - Maintaining RAAS Inhibition and Managing Hyperkalemia: Expert Insights into Best HF Patient Care

HAZLET, N.J. - EntSun -- In this symposium, HF nurses will be provided with education, through lecture and "real-world" case discussion, that will enable them to 1) use potassium binders effectively and safely with fundamental knowledge about their profiles and clinical trial evidence, and 2) communicate key information to patients about the reasons for initiating potassium binders, and using them long-term with RAAS is to reduce their risk of major adverse outcomes.

Click here for more information

CHAIR

Nancy Albert, PhD, CCNS, CHFN, CCRN, NE-BC
Associate Chief Nursing Officer--Research and Innovation

More on EntSun News

• Where Mountain Majesty Meets Movie Magic: MontanaPictureCars.com Arrives
• RAS AP Consulting Advances to Request for Proposal Stage in Heidelberg Materials' SAP Customer & Vendor Master Data Modernization Initiative
• Expert E-Bike Safety Advocate Issues Urgent Warning Following Recent Southern California Fatalities
• VeneerVibe Releases 2026 Snap-On Veneers Market Report
• David Cavanagh Launches AI SEO Company For ChatGPT And AI Search Visibility

Clinical Nurse Specialist--Kaufman Center for Heart Failure
Cleveland Clinic
Cleveland, Ohio

FACULTY

Stephanie Barnes, DNP, AGNP-C, CHFN
Clinical Director for Advanced Heart Failure
Duke University Health System
Durham, North Carolina

Stephen Greene, MD
Associate Professor of Medicine
Duke University School of Medicine
Duke Clinical Research Institute
Durham, North Carolina

Educational Objectives

• Recognize the relationship of hyperkalemia (or fear of hyperkalemia) and underuse and underdosing of RAASis in HF
• Explain the relationship between down-titration or discontinuation of RAASis and clinical outcomes
• Explain the key characteristics of, and clinical evidence with novel potassium binders
• Identify HF patients who would benefit from novel potassium binders for the treatment of hyperkalemia

Target Audience

More on EntSun News

• Matthew Cossolotto Spotlights Make a Promise Day 2026 Events, Including Official Launch of Harness Your PromisePower and Issuing a "Peace Promise"
• Landmark Expands Services to Include Specialized Glass and Glazing Solutions Across Los Angeles
• As Pentagon Releases Ufo Files, Debut Ya Novel Predicted It All
• The Artist Cultural Exchange Workshop
• MagicWave Launches Their First Female Voiced Original Audiodrama Series 'The Secret of the Succubus'

This educational activity is intended for Heart Failure Nurses.

Educational Grant
This activity is supported by an educational grant from AstraZeneca Pharmaceuticals.

Accreditation and Credit Designation Statements
This activity is provided by the American Association of Heart Failure Nurses (AAHFN). The American Association of Heart Failure Nurses (AAHFN) is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's (ANCC) Commission on Accreditation.
Attendees may earn continuing education credits (CEC) by attending the meeting and completing the evaluation for the Annual Meeting sessions. Disclaimer: Learners are advised that accredited status does not imply endorsement by the provider, additional provider, or ANCC of any commercial products displayed in conjunction with an activity. Accreditation Provider Number: ANCC Provider Number: P0398.